CSF Delivery of INS1201 AAV9-Micro-Dystrophin Demonstrates Efficacy in a Mouse Model of DMD

被引:0
|
作者
Thomsen, Gretchen [1 ]
Kaspar, Allan [1 ]
Ferraiuolo, Laura [1 ]
Chu, Binh [1 ]
Garcia, Veronica [1 ]
Slaiwa, Theresa [1 ]
Weiss, Ryan [1 ]
Cano, Robert [1 ]
Helmuth, Ashley [1 ]
Julazadeh, Hana [1 ]
Bautista, Haunani [1 ]
Downes, Melissa McAlonis [2 ]
Arnold, W. David [3 ]
Kaspar, Brian [1 ]
机构
[1] Insmed Gene Therapy, San Diego, CA USA
[2] Univ Calif San Diego, San Diego, CA USA
[3] Univ Missouri, Columbia, MO USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
398
引用
收藏
页码:216 / 217
页数:2
相关论文
共 3 条
  • [1] Systemic Delivery of nNOS-Recruiting Mini-Dystrophin AAV Vectors Ameliorated Muscular Dystrophy in a Mouse DMD Model
    Zhang, Yadong
    Duan, Dongsheng
    MOLECULAR THERAPY, 2012, 20 : S72 - S72
  • [2] Systemic AAV-Mediated Co-Delivery of Microdystrophin and CRISPR/Cas9 in a Mouse Model of DMD
    Bengtsson, Niclas E.
    Chamberlain, Jeffrey S.
    MOLECULAR THERAPY, 2018, 26 (05) : 392 - 392
  • [3] Intravenous Delivery of a rAAV9 U7snRNA Vector Targeting Exon 2 Results in Widespread Dystrophin Expression in the Dup2 DMD mouse model
    Simmons, Tabatha R.
    Vulin, Adeline
    Wein, Nicolas
    Rutherford, Andrea M.
    Janssen, Paul M.
    Flanigan, Kevin M.
    MOLECULAR THERAPY, 2014, 22 : S51 - S51